Wörwag Pharma GmbH & Co. KG
Irina Akhmadova is an experienced professional in the pharmaceutical industry, currently serving as a Brand Manager at Wörwag Pharma GmbH & Co. KG since November 2020, where responsibilities include developing strategies to position Rx products effectively. Previously, Irina held the position of Business Development Manager at Egis Pharmaceuticals PLC, managing the OTC and Woman Health portfolios, and at Glenmark Pharmaceuticals, where market analysis and collaboration with R&D were key functions. Prior roles included Project Manager and Business Development Analyst at Takeda Pharmaceuticals, focusing on project planning and market research, as well as Manager of Market Infrastructure Research at MRC Pharmexpert, emphasizing market analysis in the pharmaceutical sector. Irina began their career as a Business Development Manager at Akvion. Irina holds a Bachelor’s degree in Management and an Engineering degree in Biotechnology from Lomonosov Moscow Academy of Fine Chemical Technology.
Wörwag Pharma GmbH & Co. KG
Woerwag Pharma GmbH & Co. KG is a family-owned and international operating pharmaceutical company headquartered in Boeblingen, Germany, developing and selling biofactor preparations wordwide with more than 1400 employees in 35 countries. The company’s product rage is exclusively available in pharmacies and includes both prescription preparations as well as over the counter (OTC) products and food supplements. Therapeutic areas focus on diabetic comorbidities, diseases of the nervous system, of the musculoskeletal system, as well as on stabilizing the immune system.